LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,624 Cr | ₹602 Cr | ₹666 Cr | ₹994 Cr | ₹911 Cr |
What is the latest Cash Flow from Operating Activities ratio of LAURUS LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,624 Cr |
| Mar2025 | ₹602 Cr |
| Mar2024 | ₹666 Cr |
| Mar2023 | ₹994 Cr |
| Mar2022 | ₹911 Cr |
How is Cash Flow from Operating Activities of LAURUS LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,624 Cr | 169.84 | |
| Mar2025 | ₹602 Cr | -9.62 | |
| Mar2024 | ₹666 Cr | -33.02 | |
| Mar2023 | ₹994 Cr | 9.09 | |
| Mar2022 | ₹911 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹98,032.0 Cr | -1.5% | 16.4% | 116.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -1.5% |
16.4% |
116.4% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses